NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 240 filers reported holding NEOGENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $150,000 | -98.1% | 12,376 | -94.5% | 0.00% | -98.0% |
| Q4 2021 | $7,735,000 | -32.4% | 226,704 | -4.5% | 0.20% | -35.2% |
| Q3 2021 | $11,448,000 | +7.1% | 237,323 | +0.3% | 0.31% | +2.7% |
| Q2 2021 | $10,687,000 | -5.7% | 236,591 | +0.7% | 0.30% | -12.6% |
| Q1 2021 | $11,328,000 | -23.0% | 234,868 | -14.0% | 0.34% | -22.3% |
| Q4 2020 | $14,704,000 | +45.0% | 273,100 | -0.6% | 0.44% | +18.0% |
| Q3 2020 | $10,139,000 | +21.6% | 274,835 | +2.1% | 0.37% | +21.5% |
| Q2 2020 | $8,340,000 | +670.1% | 269,205 | +586.1% | 0.31% | +479.2% |
| Q1 2020 | $1,083,000 | -23.8% | 39,239 | -19.2% | 0.05% | -11.7% |
| Q4 2019 | $1,421,000 | +53.0% | 48,570 | 0.0% | 0.06% | +46.3% |
| Q3 2019 | $929,000 | -12.9% | 48,570 | -0.0% | 0.04% | -10.9% |
| Q2 2019 | $1,066,000 | +3.5% | 48,590 | -3.4% | 0.05% | -4.2% |
| Q1 2019 | $1,030,000 | +108.1% | 50,325 | +28.2% | 0.05% | +84.6% |
| Q4 2018 | $495,000 | – | 39,250 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,291,019 | $22,477 | 12.11% |
| Greenhouse Funds LLLP | 2,930,014 | $51,011,544 | 4.27% |
| First Light Asset Management, LLC | 2,698,958 | $46,988,859 | 4.23% |
| PERKINS CAPITAL MANAGEMENT INC | 197,000 | $3,430 | 3.23% |
| Altium Capital Management LP | 240,000 | $4,178,400 | 2.32% |
| FORMULA GROWTH LTD | 280,690 | $4,886,813 | 1.57% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 101,065 | $1,759,542 | 1.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,374,783 | $23,934,972 | 1.41% |
| EMERALD ADVISERS, LLC | 1,669,324 | $29,062,931 | 1.39% |
| Lisanti Capital Growth, LLC | 528,235 | $9,196,571 | 1.28% |